Metabolon’s Untargeted Metabolomics Services Used for Breakthrough Study Revealing Powerful Link Between Gut Microbiome, the Metabolome, and Type 2 Diabetes (T2D)
Combining metabolomics, gut microbiome, and clinical data may help prevent and personalize…
Phoenix Aviation Capital Recognized by Airfinance Global in 2025 Lessor Portfolio Risk Ratings
Prestigious Rankings Highlight Phoenix Aviation Capital's Long-Term Strategic Focus and Execution DUBLIN…
Zurich Kotak General Insurance marks its First Foundation Day with a Commitment to its Community and Commercial Insurance Launch
MUMBAI, India, June 23, 2025 /PRNewswire/ -- Zurich Kotak General Insurance (Zurich Kotak)…
EAN Congress: Frequent nightmares triple risk of early death and accelerate ageing, major study finds
HELSINKI, June 23, 2025 /PRNewswire/ -- New research presented today at the…
Bureau Expands Device Intelligence with Next-Gen Capabilities to Detect Coordinated Fraud
Built on two years of frontline fraud prevention, now reengineered as next-gen…
Aon’s 2025 Global Cyber Risk Report Reveals Reputation Risk Events Can Reduce Shareholder Value by 27 percent
DUBLIN, June 17, 2025 /PRNewswire/ -- Aon plc (NYSE: AON), a leading global…
XRP price: Massive sell-off forces holders to flock to EarnMining for stable income
Houston, Texas, June 16, 2025 (GLOBE NEWSWIRE) -- After experiencing a short-term…
MEXC Unveils “Proof of Trust” Campaign for Crypto Security, Audits, and User Protection
VICTORIA, Seychelles, June 16, 2025 /PRNewswire/ -- MEXC, a leading global cryptocurrency…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients](https://i1.wp.com/ml-eu.globenewswire.com/media/NTJlMDkyZjktNGMwNi00N2YyLTkyZmQtZTIwMWJlNzgxOWYyLTEwMTI2MjEtMjAyNS0wNi0xNS1lbg==/tiny/F-Hoffmann-La-Roche-Ltd.png?w=420&resize=420,280&ssl=1 "[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients")
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients
After a thorough clinical review, the benefit-risk for the use of Elevidys…
Zero Trust Security Reduces Cyber Insurance Claims, Preventing up to $465 Billion Annually in Global Economic Loss from Cyber Attacks
Nearly a third of the cyber events encompassed by the study potentially…